ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Email

This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Email

This field is for validation purposes and should be left unchanged.

go to the article

go back to the homepage

BIOCOM CARD
Newsletter
Advertising
Job Market
Shop

Latest news
Background
Opinion
The Mag
- Issues
- Special
- Subscribe
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

ADVERTISEMENT

Tag Archive for: ADME

©?Selvita S.A.

New headquarter in Krakow

The new Krakow headquarters of preclinical CRO Selvita have opened.

14 June 2023

https://european-biotechnology.com/wp-content/uploads/2024/04/Eastern_selvita_krakow-site.jpg 541 960 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-06-14 12:19:052024-06-21 12:53:24New headquarter in Krakow

LATEST NEWS

Jane Osbourn, Founder and CEO of Alchemab Therapeutics Ltd

Alchemab Therapeutics Ltd

Alchemab Therapeutics reports US$32m Series A exten...

The Fragile X mutation is a type of genetic mutation called a repeat expansion. This repeat expansion occurs on the FMR1 gene, on the long arm of the X chromosome leading to gene silencing if more than 200 repeats occur.

FRAXA Ewsearch Organisation

Servier acquires Kaerus Bioscience’s FXS cand...

adobe stock photos - deemerwha

NRG Therapeutics Ltd bags £50m in Series B financi...

ADVERTISEMENT

MAGAZINE

1 / 4

01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

2 / 4

EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

3 / 4

EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

4 / 4

EB324_Titel

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔

SPONSORED PUBLICATION

Messegeschehen / Trade fair activity

POWTECH TECHNOPHARM

About POWTECH TECHNOPHARM

POWTECH TECHNOPHARM (Nuremberg, 23-25 September 2025) is the international trade fair for process engineering experts and a tailor-made technology platform for the pharmaceutical and life science … more ➔

newsletter_link

© BIOCOM Interrelations GmbH

Link to LinkedIn
Link to Instagram

Contact
Imprint
Privacy policy